Tailstorm Health Inc recalls Lidocaine HCL Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug: reduced efficacy for epinephrine
- Products
-
- Lidocaine HCL Injection
- Company
- Tailstorm Health Inc
- Where it was sold
-
Nationwide in the USA
Nationwide
- Barcodes
381483003802- Units affected
- 12,525 10 mL vials
- About this recall
- Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2